Survey and case-control study during epidemics of Puumala virus infection

Epidemiology and Infection

Volumn 137, Issue 10, 2009, Pages 1479-1485

  Winter, C H ^a,b,c   Brockmann, S O ^a,b,c   Piechotowski, I ^a   Alpers, K ^b   An Der Heiden, M ^b   Koch, J ^b   Stark, K ^b   Pfaff, G ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c Postgraduate Training for Applied Epidemiology/FETP ^*  (Germany)

Author keywords

Bank vole; Burden of disease; Case control study; Epidemic; Haemorrhagic fever with renal syndrome; Hantavirus; Nephropathia epidemica; Population dynamics; Puumala virus; Survey

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLURRED VISION; CASE CONTROL STUDY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DIARRHEA; DYSPNEA; EPIDEMIC; FEMALE; GERMANY; HEADACHE; HEART FAILURE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY DISEASE; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; POPULATION DYNAMICS; PUUMALA VIRUS; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; VIRUS INFECTION; ISOLATION AND PURIFICATION; MIDDLE AGED; VIROLOGY; VIRUS HEMORRHAGIC FEVER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; DISEASE OUTBREAKS; FEMALE; GERMANY; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; MALE; MIDDLE AGED; PUUMALA VIRUS; RISK FACTORS; YOUNG ADULT;

EID: 67650706565     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809002271     Document Type: Article

References (38)

1. Plant A. Control of Communicable Diseases Manual, 18th edn. Washington, DC: American Public Health Association, 2004, pp. 240-245.
2. Zoller L, et al. Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay. European Journal of Clinical Microbiology & Infectious Diseases 1995; 14: 305-313.
3. Ahlm C, et al. Prevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden. Epidemiology and Infection 1994; 113: 129-136.
4. Brummer-Korvenkontio M, et al. Epidemiological study of nephropathia epidemica in Finland 1989-1996. Scandinavian Journal of Infectious Diseases 1999; 31: 427-435.
5. Lahdevirta J, et al. Renal sequelae to nephropathia epidemica. Acta Pathologica Microbiologica Scandinavia [A]1978; 86: 265-271.
6. Settergren B, et al. Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases. Revue of Infectious Diseases 1989; 11: 921-927.
7. Settergren B, et al. Incidence and geographic distribution of serologically verified cases of nephropathia epidemica in Sweden. American Journal of Epidemiology 1988; 127: 801-807.
8. Vapalahti O, et al. Hantavirus infections in Europe. Lancet Infectious Diseases 2003; 3: 653-661.
9. Brummer-Korvenkontio M, et al. Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. Journal of Infectious Diseases 1980; 141: 131-134.
10. Sironen T, et al. Distribution of Puumala hantavirus in Denmark: analysis of bank voles (Clethrionomys glareolus) from Fyn and Jutland. Vector Borne and Zoonotic Diseases 2002; 2: 37-45.
11. Olsson GE, et al. Hantavirus antibody occurrence in bank voles (Clethrionomys glareolus) during a vole population cycle. Journal of Wildlife Diseases 2003; 39: 299-305.
12. Ahlm C, et al. High prevalence of hantavirus antibodies in bank voles (Clethrionomys glareolus) captured in the vicinity of households afflicted with nephropathia epidemica. American Journal of Tropical Medicine and Hygiene 1997; 56: 674-678.
13. Bujalska G. Social system of the bank vole, Clethrionomys glareolus. In: Tamarin RH, Ostfeld RS, Pugh SR, Bujalska R, eds. Social Systems and Population Cycles in Voles. Basel : Birkhäuser Verlag, 1990, pp. 155-167.
14. Kallio ER, et al. Prolonged survival of Puumala hantavirus outside the host: evidence for indirect transmission via the environment. Journal of General Virology 2006; 87: 2127-2134.
15. Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerging Infectious Diseases 1997; 3: 95-104.
16. Abu SM, et al. Risk factors for hantavirus infection in Germany, 2005. Emerging Infectious Diseases 2007; 13: 1364-1366.
17. Van Loock F, et al. A case-control study after a hantavirus infection outbreak in the south of Belgium: who is at risk ? Clinical Infectious Diseases 1999; 28: 834-839. (Pubitemid 29169424)
18. Crowcroft NS, et al. Risk factors for human hantavirus infection : Franco-Belgian collaborative case-control study during 1995-6 epidemic. British Medical Journal 1999; 318: 1737-1738.
19. Robert Koch Institute. SurvStat@RKI (http://www3. rki.de/SurvStat/).
20. Essbauer S, et al. A new Puumala hantavirus subtype in rodents associated with an outbreak of Nephropathia epidemica in South-East Germany in 2004. Epidemiology and Infection 2006; 134: 1333-1344.
21. Essbauer S, et al. Nephropathia epidemica in metropolitan area, Germany. Emerging Infectious Diseases 2007; 13: 1271-1273.
22. Kimmig P, et al. Epidemiology of hantaviruses in Baden-Wurttemberg [in German]. Gesundheitswesen 2001; 63: 107-112.
23. Ulrich R, et al. Prevalence of hantavirus infections in Germany [in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2004; 47: 661-670.
24. Niklasson B, et al. Temporal dynamics of Puumala virus antibody prevalence in voles and of nephropathia epidemica incidence in humans. American Journal of Tropical Medicine and Hygiene 1995; 53: 134-140.
25. Pettersson L, et al. Outbreak of puumala virus infection, Sweden. Emerging Infectious Diseases 2008; 14: 808-810.
26. Armstrong LR, et al. Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodentinfested structures. Journal of Infectious Diseases 1995; 172: 1166.
27. German Meteorological Service. (ww.dwd.de), 2008.
28. Korpimäki E, et al. The puzzles of population cycles and outbreaks of small mammals solved? Bioscience 2004; 54: 1071-1079.
29. Mills JN. Regulation of rodent-borne viruses in the natural host: implications for human disease. Archives of Virology (Suppl.) 2005, 45-57.
30. Ulrich R, et al. Network 'Rodent-borne pathogens' in Germany: Longitudinal studies on the geographical distribution and prevalence of hantavirus infections. Parasitology Research 2008; 103(S1) : 121-129.
31. Hardestam J, et al. Puumala hantavirus excretioin kinetics in bank voles (Myodes glareolus). Emerging Infectious Diseases 2008; 8: 1209-1215.
32. Bernshtein AD, et al. Dynamics of Puumala hantavirus infection in naturally infected bank voles (Clethrinomys glareolus). Archives of Virology 1999; 144: 2415-2428.
33. Olsson GE, et al. Demographic factors associated with hantavirus infection in bank voles (Clethrionomys glareolus). Emerging Infectious Diseases 2002; 8: 924-929.
34. Linard C, et al. Environmental conditions and Puumala virus transmission in Belgium. International Journal of Health Geographics 2007; 6: 55.
35. Sauvage F, Langlais M, Pontier D. Predicting the emergence of human hantavirus disease using a combination of viral dynamics and rodent demographic patterns. Epidemiology and Infection 2007; 135: 46-56.
36. Hofmann J, et al. Hantavirus Outbreak, Germany, 2007. Emerging Infectious Diseases 2008; 14: 850-852.
37. Linard C, et al. Determinants of the geographic distribution of Puumala virus and Lyme borreliosis infections in Belgium. International Journal of Health Geographics 2007; 6: 15.
38. Piechotowski I, et al. Emergence of Hantavirus in South Germany: Rodents, climate and human infections. Parasitology Research 2008; 103(S1) : 131-137.